rethinkPeptides Search
Menu
Study breakdown

Children and Adults Mount Different Defensin and Interferon Responses to COVID-19

Observational StudyModerate evidence
The takeaway

Children with COVID-19 selectively upregulate IFN-λ1 in the nose, while adults and elderly instead activate IFN-α/β and β-defensins 1-3, suggesting age-related innate immune differences explain COVID-19 severity patterns.

Age-specific immune patterns

Children selectively activate IFN-λ1 while adults/elderly activate IFN-α/β plus β-defensins — fundamentally different innate responses to the same virus

What the researchers found

SARS-CoV-2 infection induced selective IFN-λ1 upregulation in children (≤15 years) without β-defensin changes, while adults (15-65) and elderly (≥65) showed IFN-α/β and β-defensin 1-3 upregulation without IFN-λ1 modulation. 226 subjects analyzed.

Why it matters

Understanding why children resist severe COVID-19 could inform treatments for adults. The finding that children use a different, more targeted innate immune response — and that defensin responses differ by age — has implications for future pandemic preparedness.

The numbers in context

226 individuals; 3 age groups; IFN-lambda-1 selective in children under 15; beta-defensins 1-3 upregulated in adults/elderly only

How the study worked

Cross-sectional study. Nasopharyngeal swabs from 226 individuals (children, adults, elderly; SARS-CoV-2 positive/negative). mRNA expression of type I/III interferons, β-defensins 1-3, α-defensins, LL-37, pentraxin-3, surfactant protein D, IL-26, IFITM1/3 measured.

Who was studied

226 individuals across three age groups (children, adults, elderly), SARS-CoV-2 positive and negative

What this study cannot tell us

Cross-sectional design cannot establish causation. mRNA levels may not reflect protein levels. Nasopharyngeal samples represent local, not systemic immunity. Functional significance of the different defensin/interferon patterns needs direct testing.

How to read the evidence

Moderate evidence: well-powered cross-sectional study (226 subjects) with clear age-stratified results, but observational design limits causal conclusions.

When this study was published

Published 2021. Understanding of COVID-19 age-related immunity has continued to evolve with additional studies.

The bigger picture

This study provides molecular evidence that innate immune maturation — specifically the balance between interferons and antimicrobial peptides — determines COVID-19 susceptibility. It suggests that the adult/elderly innate response, while more aggressive, may paradoxically contribute to disease severity.

Questions still open

  • Could mimicking children's IFN-λ1-dominant response protect adults from severe COVID-19?
  • Does the β-defensin upregulation in adults contribute to inflammation rather than protection?
  • Are these age-related innate immune differences consistent across other respiratory viruses?

Common questions

Why do children get less sick from COVID-19?
This study suggests children mount a more targeted innate immune response — activating specifically IFN-λ1 without triggering the broader inflammatory cascade (IFN-α/β and β-defensins) that adults produce. The adult response may paradoxically contribute to tissue damage and severe disease.
What role do defensins play in COVID-19?
Adults and elderly upregulate β-defensins 1-3 in response to SARS-CoV-2 infection while children do not. While defensins normally fight infections, their activation in this context may be part of the excessive inflammatory response associated with severe COVID-19.

Read the original research

Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals.

Frontiers in immunology, 12, 750279

Citation

Gilbert, Charly; Lefeuvre, Caroline; Preisser, Laurence; Pivert, Adeline; Soleti, Raffaella; Blanchard, Simon; Delneste, Yves; Ducancelle, Alexandra; Couez, Dominique; Jeannin, Pascale. (2021). Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals.. Frontiers in immunology, 12, 750279. https://doi.org/10.3389/fimmu.2021.750279